Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1999 1
2002 3
2005 1
2007 2
2008 1
2009 1
2012 2
2013 4
2014 1
2015 2
2021 1
2023 5
2024 4
2025 4
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.
Egeler MD, Klobuch S, Tak WS, Rohaan MW, Borch TH, Noringriis IM, Tissier R, Lucas MW, van Houdt W, van Akkooi ACJ, Jedema I, Donia M, Blank CU, Svane IM, Haanen JBAG, van de Poll-Franse LV. Egeler MD, et al. Eur J Cancer. 2025 Sep 9;227:115640. doi: 10.1016/j.ejca.2025.115640. Epub 2025 Jul 13. Eur J Cancer. 2025. PMID: 40674829 Clinical Trial.
Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.
Ten Ham RMT, Rohaan MW, Egeler M, Menezes R, Holz Borch T, Kessels R, Jedema I, Nuijen B, Nijenhuis CM, van de Poll-Franse LV, Geukes Foppen MH, Lindenberg M, Mansfield Noringriis I, Monberg TJ, Donia M, van Harten W, Svane IM, Haanen JBAG, Retèl VP. Ten Ham RMT, et al. Among authors: egeler m. Ann Oncol. 2025 Oct;36(10):1154-1165. doi: 10.1016/j.annonc.2025.06.005. Epub 2025 Jun 18. Ann Oncol. 2025. PMID: 40541863 Free article. Clinical Trial.
Will post-transplantation cell therapies for pediatric patients become standard of care?
Lankester AC, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, Pulsipher MA, Nierkens S, Schultz K, Handgretinger R, Grupp SA, Boelens JJ, Bollard CM; Westhafen Intercontinental Group. Lankester AC, et al. Among authors: egeler m. Biol Blood Marrow Transplant. 2015 Mar;21(3):402-11. doi: 10.1016/j.bbmt.2014.07.018. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2015. PMID: 25064748 Free article. Review.
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.
Louis FM, van der Voort A, van Ramshorst MS, Daletzakis A, Mandjes IA, Kemper I, Agterof MJ, van der Steeg WA, Heijns JB, van Bekkum ML, Siemerink EJM, Kuijer PM, Scholten A, Wesseling J, Vrancken Peeters MTFD, Egeler MD, van de Poll-Franse LV, Mann RM, Sonke GS; Dutch Breast Cancer Research Group (BOOG). Louis FM, et al. Among authors: egeler md. Lancet Oncol. 2026 Mar;27(3):349-360. doi: 10.1016/S1470-2045(25)00707-7. Epub 2026 Feb 16. Lancet Oncol. 2026. PMID: 41713473 Clinical Trial.
Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review.
Egeler MD, van Leeuwen M, Fraterman I, van den Heuvel NMJ, Boekhout AH, Lai-Kwon J, Wilthagen EA, Eriksson H, Haanen JB, Wilgenhof S, Ascierto PA, van Akkooi ACJ, van de Poll-Franse LV. Egeler MD, et al. Crit Rev Oncol Hematol. 2023 Mar;183:103919. doi: 10.1016/j.critrevonc.2023.103919. Epub 2023 Feb 1. Crit Rev Oncol Hematol. 2023. PMID: 36736511
Online Indicated Preventive Mental Health Interventions for Youth: A Scoping Review.
van Doorn M, Nijhuis LA, Egeler MD, Daams JG, Popma A, van Amelsvoort T, McEnery C, Gleeson JF, Öry FG, Avis KA, Ruigt E, Jaspers MWM, Alvarez-Jimenez M, Nieman DH. van Doorn M, et al. Among authors: egeler md. Front Psychiatry. 2021 Apr 29;12:580843. doi: 10.3389/fpsyt.2021.580843. eCollection 2021. Front Psychiatry. 2021. PMID: 33995136 Free PMC article.
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias.
Fierro-Pineda JC, Tsai HL, Blackford A, Cluster A, Caywood E, Dalal J, Davis J, Egeler M, Huo J, Hudspeth M, Keating A, Kelly SS, Krueger J, Lee D, Lehmann L, Madden L, Oshrine B, Pulsipher MA, Fry T, Symons HJ. Fierro-Pineda JC, et al. Among authors: egeler m. Blood Adv. 2023 Sep 26;7(18):5639-5648. doi: 10.1182/bloodadvances.2023010281. Blood Adv. 2023. PMID: 37257193 Free PMC article.
35 results